#AZN
-

AstraZeneca Stock Rises as Defensive Pharma Trade Gains Momentum
AstraZeneca shares climbed more than 4% as investors rotated into defensive healthcare stocks amid rising bond yields and persistent inflation.…
-

AstraZeneca Shares Drop 5.7% After Wainua Phase 3 Trial Miss
AstraZeneca lost about $24 billion in market value after Wainua failed a pivotal Phase 3 heart trial. Investors are now…